Medical paternalism and expensive unsubsidised drugs. by Jefford, M, Savulescu, J, Thomson, J, Schofield, P, Mileshkin, L, Agalianos, E, Zalcberg, J

Do oncologists discuss expensive anti-cancer drugs with their patients? by Thomson, J, Schofield, P, Mileshkin, L, Agalianos, E, Savulescu, J, Zalcberg, J, Jefford, M

What are the unmet support needs of women with a known BRCA1/2 mutation? by White V, Farrelly A, Meiser B, Jefford M, Young M, Winship I, Ieropoli S, Koehler J

Get full text

To tell or not to tell: the community wants to know about expensive anticancer drugs as a potential treatment option. by Mileshkin, L, Schofield, P, Jefford, M, Agalianos, E, Levine, M, Herschtal, A, Savulescu, J, Thomson, J, Zalcberg, JR

Ethics review of COVID-19 human challenge studies: a joint HRA/WHO workshop by Williams, E, Craig, K, Chiu, C, Davies, H, Ellis, S, Emerson, C, Jamrozik, E, Jefford, M, Kang, G, Kapulu, M, Kolstoe, SE, Littler, K, Lockett, A, Elena Rey, Messer, J, McShane, H, Saenz, C, Selgelid, MJ, Shah, S, Smith, PG, Yamazaki, N